Patterns of psychostimulant prescribing to children with ADHD in Western Australia: Variations in age, gender, medication type and dose prescribed

Australian and New Zealand Journal of Public Health

Volumn 31, Issue 2, 2007, Pages 120-126

  Preen, David B ^a   Calver, Janine ^b   Sanfilippo, Frank M ^a   Bulsara, Max ^a,c   Holman, C D'Arcy J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

ADHD; Dexamphetamine; Medicines; Methylphenidate; Paediatrics

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; SEX RATIO; SUSTAINED RELEASE PREPARATION;

ADOLESCENT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DEXTROAMPHETAMINE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PREVALENCE; SEX FACTORS; WESTERN AUSTRALIA;

EID: 34247334930     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2007.00028.x     Document Type: Article

References (43)

1. Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med. 1995;333:944.
2. Berbatis CG, Sunderland VB, Bulsara M. Licit stimulant consumption in Australia, 1984-2000: international and jurisdictional comparison. Med J Aust. 2002;177:529-34.
3. Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6): 1071-7.
4. Mackey P, Kopras A. Medication for Attention Deficit/Hyperactivity Disorder (ADHD) : An Analysis by Federal Electorate. Canberra (AUST): Parliamentary Library of Australia; 2001 April 3. Current Issues Brief 11 2000-01.
5. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol. 1998;39(1):65-99.
6. DeBar LL, Lynch FLL, Boles M. Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. J Behav Health Serv Res. 2004;31(3):312-23.
7. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. J Am Med Assoc. 2001;285(1):60-6.
8. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilisation of cost of health care services for children with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108(1):71-8.
9. Harpaz-Rotem I, Rusenheck RA. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness. Child Care Health Dev. 2005;32(2):225-37.
10. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics. 1997;100(4):662-6.
11. National Health and Medical Research Council. Attention Deficit Hyperactivity Disorder. 1st ed. Canberra (AUST): AGPS; 1996.
12. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, et al. Are stimulants over prescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry. 1999;37:797-804.
13. Safer D, Malever M. Stimulant treatment in Maryland public schools. Pediatrics. 2000;106:533-9.
14. Zito JM, Safer D, dosReis S, Magder LS, Riddle MA. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull. 1997;33(1):143-7.
15. Hugtenburg JG, Heerdink ER, Egberts ACG. Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate in boys. Eur J Clin Pharmacol. 2004;60:377-9.
16. Rowland AS, Umbach DM, Stallone L, Naftel AJ, Bohlih EM, Sander DP. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health. 2001;92(2):231-4.
17. LeFever GB, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health. 1999;89:1359-64.
18. Jick H, Kaye JA, Black C. Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK. Br J Gen Pract. 2004;54:345-7.
19. Faber A, de Jong-van den Berg LTW, van den Berg PB, Tobi H. Psychotropic co-medication among stimulant-treated children in the Netherlands. J Child Adolesc Psychopharmacol. 2005;15(1):38-43.
20. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories. Canberra (AUST): ABS; 2005. Report No.: 3201.0.
21. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva (CHE): WHO; 1992.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington (DC): American Psychiatric Press; 1994.
23. Kelman CW, Bass AJ, Holman CDJ. Research use of linked health data - a best practice protocol. Aust N Z J Public Health. 2002;26(3):251-55.
24. Altman DG. Practical Statistics for Medical Research. London (UK): Chapman Hall; 1991.
25. Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, et al. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics. 1999;103:43.
26. Pharmaceutical Services Branch. Stimulant Prescribing and Usage Patterns for the Treatment of ADHD in Western Australia (1 August 2003 - 31 December 2004). Perth (AUST): Western Australian Department of Health, 2005.
27. Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust. 2002;177:21-5.
28. Valentine J, Zubrick S, Sly P. National trends in the use of stimulant medication for attention deficit hyperactivity disorder. J Pediatr Child Health. 1996;32:223-7.
29. NSW Department of Health. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in NSW. N S W Public Health Bull. 2002;13(S1).
30. Sparke C. The ADHD epidemic. Australian Doctor. 2000;April 26:31-3.
31. Swan N. Attention Deficit Hyperactivity Disorder (ADHD). In: The Health Report [radio program]. Sydney (AUST): ABC Radio National; 2000 October 23.
32. Habel LA, Schaefer CA, Levine P, Bhat AK, Elliot G. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol. 2005;15(1):62-7.
33. Vance A, Luk E. Attention deficit hyperactivity disorder: current progress and controversies. Aust N Z J Public Health. 2000;34(5):719-30.
34. Sawyer M, Rey J, Graetz B, Clark J, Baghurst P. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust. 2005;177:21-5.
35. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159:36-42.
36. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997;36:1036-45.
37. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry. 1995;34:629-38.
38. Keen D, Bramble D, Olurin-Lynch J. Attention-deficit hyperactivity disorder: how much do we see? Child Psychol Psychiatry Rev. 2000;5:164-8.
39. Shaffer D. Attention-deficit hyperactivity disorder in adults. Am J Psychiatry. 1994;151(633-8).
40. Rumberger RW. Dropping out of high school: the influence of race, sex and family background. American Educational Research Journal. 1983;20(2):199-220.
41. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319-24.
42. MIMS annual online database [homepage on the Internet]. Sydney (AUST): CMPMedica; 2006 [cited 2006 Nov 10]. Australian Medication Information Management System. Available from: www.mims.com.au
43. Phillips T, Salmon G, James AC. Prescribing practices in child and adolescent psychiatry: Change over time 1993-2000. Child and Adolescent Mental Health. 2003;8(1):23-8.